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Available online 27 June 2016AbstractPurpose: To compare dry eye signs and symptoms between patients with preoperative low and normal Schirmer test after Photorefractive
keratectomy (PRK).
Methods: In this prospective, nonrandomized, comparative case series, 76 eyes of 76 patients were preoperatively categorized into two groups
according to selected criteria for characterization of tear film status: the low Schirmer test value (STV) group and the normal STV group. For the
tear function assessment, we performed a Schirmer test with and without anesthesia, tear break-up time (TBUT) test, and measurement dry eye
symptoms using the Farsi translation of Ocular Surface Disease Index (OSDI) questionnaire pre- and 3 months post-operation.
Results: Postoperatively, the Schirmer and TBUT values were significantly lower in both groups than preoperatively (all p < 0.05). Deterioration
in tear secretion was significantly greater in the low STV group (p ¼ 0.012), but tear stability was more compromised in the normal STV group
(p ¼ 0.021). The changes in OSDI score were not significant between the two groups.
Conclusion: These results demonstrated that tear function deteriorates after PRK. Therefore, patients with low preoperative Schirmer test values
should be thoroughly assessed for dry eye before proceeding with refractive surgery to eliminate postoperative complication.
Copyright © 2016, Iranian Society of Ophthalmology. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Dry eye is one of the most common reported and observed
findings in the short-term following photorefractive
procedures.1e10 Although it is usually transient, some patients
complain of severe symptoms, which may negatively influenceFinancial disclosure: No author has a financial or proprietary interest in
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).the quality of life and their satisfaction with the outcome of
the procedure.11e15
The pathophysiologic mechanisms behind post-
photorefractive surgery dry eye have been previously
reviewed, and several hypotheses have been proposed.16e18
Photorefractive surgery compromises the corneal sensory
nerve, resulting in impaired corneal sensation. Decreased
afferent input to the lacrimal functional unit results in
decreased tear secretion, leading to a deficient aqueous
component of the tear film.
Furthermore, according to some previous studies, pre-
existing dry eye disease is a major risk factor for severe
post-operative dry eye with lower tear function and moreosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND
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particular importance, and its preoperative value has been re-
ported to statistically significantly correlate with postoperative
tear break-up time (TBUT) for up to 9 months in a study.23
Schirmer 1 of less than 10 mm (at 5 min) was associated
with increased risk of postoperative dry eye at one month
postoperatively.22
Few studies exist in literature investigating the effect of
preoperative tear function on development of postoperative
dry eye sign and symptoms.24,25 It is uncertain if preoperative
Schirmer test value (STV) is a predictive factor for the
development of more dry eye symptoms after surgery.
In this study, we compare the objectively-measured clinical
signs and subjective reporting of dry eye symptoms between
two groups of patients who underwent Photorefractive kera-
tectomy (PRK) over a period of 3 months.
Methods
In this prospective, nonrandomized, comparative case se-
ries study, 76 eyes of 76 patients (46 female, 30 male) with
low-to-moderate myopia and astigmatism who were scheduled
for PRK in Persian Eye Clinic were enrolled. One eye (right
eye) from each patient was included. The research followed
the tenets of the Declaration of Helsinki, and informed consent
was obtained from all subjects. The study protocol was
approved by the Ethics Committee of Shahid Beheshti
University of Medical Sciences.
The eyes were divided into the following 2 groups on the
basis of preoperative tear secretion: eyes with low Schirmer
test value (low STV group; 36 patients and 36 eyes) and
normal Schirmer test value (normal STV group; 40 patients
and 40 eyes). Results of Schirmer 1 test were used as
selected criteria for classification of patients. The eyes with
Schirmer test values between 5 and 10 mm were considered
for the low STV group, and eyes with Schirmer test
values > 10 mm were considered for the normal STV group.
Patients who had any contraindication of corneal refractive
surgery and/or severe signs and symptoms of dry eye were
excluded from the study.
All patients had a complete ophthalmic examination
including uncorrected and corrected distance visual acuity
(UDVA and CDVA), manifest and cycloplegic refraction, slit
lamp microscopy, corneal topography and pachymetry (Pen-
tacam HD, Oculus Optikgerate GmbH, Wetzlar, Germany),
indirect ophthalmoscopy, and tear film function assessment.
To assess tear function, all patients completed the Farsi
translation of Ocular Surface Disease Index (OSDI)26 ques-
tionnaire and underwent evaluation of tear secretion with
Schirmer test (with and without anesthesia) and tear film
stability with TBUT test prior and 3 months after surgery.
Schirmer test was performed without anesthesia (Schirmer
1) and also with anesthesia 5 min after instilling one drop of
tetracaine 0.5% into the conjunctival sac (Schirmer 2) for test
the paper strips (OPHTECHNICS UNLIMITED, India) were
placed over the junction of the temporal and medial one-thirdof the lower eyelid margin. The eyes were closed during the
test, and the length of the wet portion was measured.
TBUT was assessed with fluorescein paper strips that were
wetted with unpreserved saline solution. One drop was
instilled in each eye in the lower conjunctival sac, and the
patient was instructed to blink several times. The tear BUT
was measured as the number of seconds between the last
complete blink and the first sign of break in the precorneal tear
film. The TBUT was repeated 3 times and averaged.
For the OSDI questionnaire, the total points were multi-
plied by 25 and then divided by the total number of responses.
To study the severity of symptoms, OSDI scores were grouped
as normal (0e12), mild (13e22), moderate (23e32), and se-
vere (33) as described previously in other studies.27
All tear function tests were conducted in a quiet room of
relatively constant temperature and humidity. The same
experienced observer performed all measurements.
All surgeries were performed by one surgeon (M.G.) using
Technolas 217 z100 excimer laser system (Bausch & Lomb,
Rochester, NY). After topical anesthesia (Tetracaine 0.5%), an
eyelid speculum was inserted. The amount of ablation per-
formed was based on cycloplegic refraction and the patients'
age. mitomycin C (MMC) 0.02% was applied to the stromal
bed for up to 60 s. The surface was irrigated with a balanced
salt solution. After PRK, topical antibiotics were instilled, and
a bandage contact lens (Acuvue; Johnson & Johnson Vision
Care, Jacksonville, FL) was applied.
All tear function tests were performed at least 5 days before
surgery and also we followed the same postoperative eye drop
protocol in all eyes. Postoperative treatment included Cipro-
floxacin eye drops 4 times and Betamethasone 0.1% eye drops
6 times daily. On day 6 of follow-up, patients were assessed
for complete corneal epithelial healing and consequently,
contact lenses were removed. Up to 1 month after surgery,
Fluorometholone and lubricant eye drops were used 4 times
daily, and then Fluorometholone was tapered slowly the
following 4 weeks.
Postoperative follow-up evaluation was scheduled 3 months
after surgery. A complete ophthalmic examination including
visual, refractive, and tear film function assessment was done.
The main outcome measures of interest were the Schirmer and
TBUT tests as clinical markers for tear film function and
OSDI questionnaire as a subjective indicator of patients'
experience of dry eye symptoms, with a comparison of these
parameters between the two groups.Statistical analysisWe performed statistical analysis using SPSS software
version 20.0 for Windows (SPSS, Chicago, IL, USA). The
Chi-square test was used to compare the differences between
Normal and Low STV groups. . The pre- and post-operative
values were compared for each group by paired t test. Pear-
son's correlation test was used to assess the relationship be-
tween the studied parameters. Results were explained as
mean ± SD. p < 0.05 was considered statistically significant.
Fig. 2. Tear film stability (TBUT) before and after photorefractive keratectomy
(PRK) in the low and normal STV groups.
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Preoperatively, there were no significant differences be-
tween the two groups in age, gender, spherical equivalent (SE)
refraction, and visual acuity (Table 1).
Preoperatively, the mean Schirmer test values were
8.36 ± 1.87 mm and 29.0 ± 6.78 mm in the low and normal
STV groups, respectively (p < 0.001). It decreased to
6.17 ± 2.44 mm and 24.97 ± 9.21 mm 3 months after surgery
(Fig. 1). The change in the two groups was statistically sig-
nificant (both p < 0.001), but the change in tear secretion was
significantly greater in the low STV group (p ¼ 0.012).
The mean TBUT scores were 11.17 ± 2.51 s and
18.32 ± 4.57 s before, and 9.03 ± 1.96 s and 13.77 ± 5.36 s 3
months after surgery in the low and normal STV groups,
respectively (p < 0.001) (Fig. 2). The decrease in TBUT
scores was statistically significant in both groups (both
p < 0.001). The change was greater in the normal STV group
(p ¼ 0.021) (Table 2).
The mean preoperative OSDI scores were 13.46 ± 7.11 and
14.52 ± 8.10 (p ¼ 0.668) which changed to 16.23 ± 10.58 and
16.00 ± 10.15 at 3 months in the low and normal STV groups,
respectively (p ¼ 0.947) (Fig. 3). There were no significant
differences between the two groups of participants for theirTable 1
Demographic data of the subjects included in this study.
Low
STV
Normal
STV
p Value
Age 26.19 ± 3.79 27.82 ± 3.42 0.053
Gender,
female/male
26/14 20/16 0.408
Preoperative
SE, D
3.56 ± 1.23
(1.25 to 6.00)
3.17 ± 1.17
(1.25 to 5.25)
0.156
Mean log
Mar UDVA
0.95 ± 0.39
(0.2e1.3)
1.00 ± 0.38
(0.15e1.3)
0.435
Mean log Mar CDVA 0.06 ± 0.09
(0.0e0.3)
0.04 ± 0.05
(0.0e0.2)
0.362
SE, spherical equivalent; UDVA, uncorrected distance visual acuity; CDVA,
corrected uncorrected distance visual acuity.
Fig. 1. Schirmer values before and after photorefractive keratectomy (PRK) in the lo
B: Schirmer with anesthesia (Schirmer 2).OSDI scores and between pre- and postoperative scores in
each group.
Correlation between TBUT and Schirmer values were sig-
nificant (p < 0.001), but there was no significant correlation
between OSDI score with TBUT (p ¼ 0.803) and Schirmer
values (p ¼ 0.864).
Discussion
Dry eye is the most common postoperative complication in
the vast majority of patients who undergo photorefractive
procedures.1e10 It is also found that dry eye may enhance the
corneal haze after PRK.28 A normal tear film layer plays a
significant role in the ocular comfort and patient's satisfaction
of operation11e15 and is important in the healing of the stroma
and epithelium.29 Therefore, tear function assessment is
essential before any corneal ablation.
There is still no gold standard model for evaluating tear
film function and determining dry eye severity30e32 Tearw and normal STV groups. A: Schirmer value without anesthesia (Schirmer 1);
Table 2
Postoperative tear function changes in the two study groups.
Low STV absolute
change (variation ratio)
Normal STV absolute
change (variation ratio)
p Value
Schirmer
1 change
2.19 ± 1.74 (0.28) 4.02 ± 6.49 (0.15) 0.012
Schirmer
2 change
1.47 ± 1.71 (0.24) 4.20 ± 5.72 (0.17) 0.099
TBUT 2.14 ± 1.46 (0.18) 4.55 ± 3.26 (0.26) 0.021
OSDI score 2.77 ± 8.15 (0.35) 1.48 ± 7.75 (0.20) 0.558
TBUT, tear break-up time; OSDI, Ocular Surface Disease Index questionnaire.
Fig. 3. Dry eye symptoms (OSDI scores) before and after photorefractive
keratectomy (PRK) in the low and normal STV groups.
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symptom-based questionnaires. A number of questionnaires
have been developed and employed in both epidemiological
studies and clinical research. Among the symptom question-
naires available, OSDI is one of the most widely used ques-
tionnaires.26,33,34 Objective markers can be measured with the
tear and corneal function tests, consisting of Schirmer test to
assess tear secretion (basal and reflex), TBUT to assess tear
film stability, and Rose Bengal and corneal fluorescein dye
staining to assess corneal epithelial integrity, tear film osmo-
larity, lysozyme, and lactoferrin assays.35e37 Although tear
osmolarity measurement is currently the most sensitive and
specific diagnostic test for dry eye, the Schirmer test, despite
its inaccuracy, remains the mainstay among these in-
vestigations in the clinical diagnosis of dry eye because of
ease and better availability.35e38
In this study, we investigated tear secretion, tear film sta-
bility, and dry eye symptoms after PRK and compared their
values between eyes with preoperative low and normal
Schirmer test values. We tried to improve the accuracy of the
Schirmer test by performing the test with topical anesthesia
(Schirmer 2), eye closure, and proper position of the strips as
suggested by Holly et al.38
A reduction in Schirmer values was observed for both
normal and low STV groups 3 months after surgery. However,
deterioration in tear secretion was significantly greater in thelow STV group (p ¼ 0.012). Based on these findings, we
expected severity of symptoms to be higher in the low STV
group postoperatively, as previous studies demonstrated pa-
tients with preoperative dry eye exhibited more severe symp-
toms and ocular surface damage after photorefractive surgery
compared with non-preexisting dry eye patients.20e25 Based
on our study, however, 3 months after surgery, no differences
in subjective patient experience of dry eye symptoms between
patients with preoperative normal and low Schirmer test values
as demonstrated by results of OSDI were noted. Moreover, the
differences between pre- and post-operative OSDI scores were
not significant in either group. These findings conflicted with
some previous comparative studies.20e25 Additionally,
although the decrease in TBUT scores was statistically sig-
nificant in both groups, tear film stability was more compro-
mised in the normal STV group (p ¼ 0.021).
At present, we do not have a clear explanation for these
findings. It is difficult to understand the impact of tear film
dysfunction on a patient, as many patients that show early
clinical signs of dry eye disease may be asymptomatic, while
others may report symptoms greater than their clinical signs.
Based on clinical findings of previous studies, no consistent
relationship and correlation exist between any of the common
signs and symptoms of dry eye and between commonly used
clinical tests.31,39e42
However, previous studies have also revealed that the
severity of dry eye affect on range of observed values of each
sign, and patients with mild/moderate dry eye have a dynamic
range of test values.30,43,44 Therefore, the correlation between
sign and symptoms is probably stronger in eyes with severe
dry eye. This indicates that although preoperative tear function
plays an important role in postoperative tear secretion and
stability, in eyes with preoperative mild dry eye, it may not
lead to more symptoms after surgery.
Moreover, in this study, there was not a significant corre-
lation between Schirmer test and OSDI. Previous studies have
found that the Schirmer test may not be a good indicator for
symptoms. The reason may be poor repeatability of Schirmer
test.45 Also, the decrease in Schirmer values may not be
enough to induce the symptoms.
Clinical signs alone seem insufficient to delineate those
who have dry eye and those who do not, especially in the early
stages of tear film dysfunction. A positive diagnosis of dry eye
is often based heavily on the presence of symptoms, with
literature suggesting that symptoms are an essential compo-
nent of the disease.
This study had some limitations including performing only
two clinical indicators of dry eye (Schirmer and TBUT tests)
and a follow-up period of 3 months. A more comprehensive
combination of assessments would provide a more accurate
diagnosis of dry eye status. This would include a measure of
tear osmolarity, corneal sensitivity, TBUT, Schirmer test, and
corneal staining tests.
In conclusion, this study demonstrated decreased tear
secretion after PRK. The authors suggest that patients who
receive PRK should be informed of this risk, especially those
with preoperative borderline tear secretion. However, any
180 E. Tanbakouee et al. / Journal of Current Ophthalmology 28 (2016) 176e180refractive surgery candidate with signs or symptoms of dry eye
should be stringently evaluated preoperatively. Additionally,
proper management for tear function are required following
surgery to eliminate complications.
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